ZE5-20187-68032
4 vaccinations
4 coded responses
30 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 038 / NH
- Registered
- 2021-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- 3BG-23401-65126
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-28
Dose 1 — Pfizer-BioNTech
-
2021-06-25
Dose 2 — Pfizer-BioNTech
-
2021-06-26
Registered in v-safe
-
2021-06-26
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do their normal daily activitiesAdult check-in
-
2021-06-27
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-28
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-06-29
- 2021-07-01
-
2021-07-02
Survey response — day 7, dose 2, dependentMedDRA: Dizziness — Feeling: Fair · Headache, Fatigue or tiredness, NauseaFree text: Light HeadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-09
- 2021-07-18
- 2021-07-23
- 2021-07-30
- 2021-08-08
- 2021-09-24
-
2021-12-24
Survey response — 6 months, dose 2, dependentMedDRA: Ear infection, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Ear infection after a cold but negative for COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Report sent to call center — 6 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-27
- 2022-01-21
-
2022-02-06
Dose 3 — Pfizer-BioNTech
- 2022-02-23
- 2022-02-27
- 2022-03-06
- 2022-03-13
- 2022-03-20
- 2022-05-08
- 2022-08-07
-
2022-10-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-16
Survey response — days 1–6 daily, dose 4, dependentMedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: Mild swelling of lymph nodes in armpitMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Survey response — days 1–6 daily, dose 4, dependentMedDRA: Oedema peripheral — Feeling: GoodFree text: Slightly swollen armpit on the side of the injection, receded the next dayMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-28
- 2022-11-06
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2023-01-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-28 | Pfizer-BioNTech | No |
| 2 | 2021-06-25 | Pfizer-BioNTech | No |
| 3 | 2022-02-06 | Pfizer-BioNTech | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — day 7, dose 2, dependent
Systemic reaction (other): Light Headedness
Release 10 — 6 months, dose 2, dependent
Symptoms: Ear infection after a cold but negative for COVID-19
Release 12 — days 1–6 daily, dose 4, dependent
Systemic reaction (other): Mild swelling of lymph nodes in armpit
Systemic reaction (other): Slightly swollen armpit on the side of the injection, receded the next day
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release